Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-10-20FDA Approved: NUZYRA — Supplemental Application (Paratek Pharmaceuticals, Inc.)
FDA's supplemental application for NUZYRA (omadacycline) submitted by Paratek Pharmaceuticals, Inc., with the submission status indicated as…
-
FDA approval · 2020-09-09FDA Approved: CEFTRIAXONE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application for Ceftriaxone and Dextrose from B. Braun Medical, resulting in an updated/expanded approval for th…
-
FDA approval · 2020-06-03FDA Approved: AMOXICILLIN — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for amoxicillin submitted by Sandoz Inc.
-
FDA approval · 2020-05-01FDA Approved: AZITHROMYCIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZITHROMYCIN from Lupin Pharmaceuticals, Inc., signaling an update to the product's regulatory a…
-
FDA approval · 2020-05-01FDA Approved: AZITHROMYCIN DIHYDRATE — Supplemental Application (Precision Dose, Inc.)
FDA approved a supplemental application for azithromycin dihydrate submitted by Precision Dose, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-04-22FDA Approved: LEVOFLOXACIN — Original Application (Gland Pharma Limited)
FDA approved an original application for levofloxacin from Gland Pharma Limited, authorizing a generic version of the antibiotic.
-
FDA approval · 2020-03-09FDA Approved: CEFDINIR — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for CEFDINIR (cefdinir) from Aurobindo Pharma Limited, a generic cephalosporin antibiotic.
-
FDA approval · 2020-02-11FDA Approved: CEFDINIR — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for CEFDINIR (cefdinir) submitted by Sandoz Inc.
-
FDA approval · 2020-01-28FDA Approved: AZITHROMYCIN — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals' original application for AZITHROMYCIN, granting a generic azithromycin product for the same indication…
-
FDA approval · 2020-01-27FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Amoxicillin and clavulanate potassium by Sandoz Inc.
-
FDA approval · 2020-01-23FDA Approved: AZITHROMYCIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for azithromycin filed by Aurobindo Pharma Limited.
-
FDA approval · 2019-04-19FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the Original Application for Amoxicillin and clavulanate potassium from Aurobindo Pharma Limited, a generic antibiotic product.
-
FDA approval · 2019-03-19FDA Approved: ERTAPENEM — Original Application (Apotex Corp)
FDA approved Apotex Corp's original application for ertapenem sodium (ertapenem), a broad-spectrum carbapenem antibiotic, as a generic produ…
-
FDA approval · 2018-12-07FDA Approved: AZITHROMYCIN — Original Application (Lannett Company, Inc.)
FDA approves Lannett Company, Inc.'s original application for azithromycin (AZITHROMYCIN), a generic antibiotic.
-
FDA approval · 2018-10-02FDA Approved: NUZYRA — Original Application (Paratek Pharmaceuticals, Inc.)
FDA approved NUZYRA (omadacycline) from Paratek Pharmaceuticals as an original application. The approval covers acute bacterial skin and ski…
-
FDA approval · 2018-09-24FDA Approved: AZITHROMYCIN DIHYDRATE — Original Application (Precision Dose, Inc.)
FDA approved azithromycin dihydrate as a generic drug under Original Application by Precision Dose, Inc., expanding access to this antibioti…
-
FDA approval · 2018-08-02FDA Approved: TIGECYCLINE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for tigecycline, authorizing a generic injectable antibiotic. It covers indic…
-
FDA approval · 2018-07-05FDA Approved: AZITHROMYCIN — Original Application (Aurobindo Pharma Limited)
FDA approved a generic azithromycin product under an Original ANDA for Aurobindo Pharma Limited.
-
FDA approval · 2018-06-25FDA Approved: ERTAPENEM — Original Application (Eugia US LLC)
The FDA approved an original application for ertapenem from Eugia US LLC, authorizing a generic version of the carbapenem antibiotic ertapen…
-
FDA approval · 2016-07-26FDA Approved: MOXIFLOXACIN — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for moxifloxacin hydrochloride (MOXIFLOXACIN) from Fresenius Kabi USA, LLC, indicating a modificatio…
-
FDA approval · 2016-06-29FDA Approved: CEFTRIAXONE SODIUM — Original Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved the Original Application for ceftriaxone sodium from Qilu Pharmaceutical Co., Ltd., a broad-spectrum cephalosporin used to trea…
-
FDA approval · 2016-04-12FDA Approved: CEFUROXIME — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Cefuroxime, adding an additional approved use/formulation under t…
-
FDA approval · 2015-07-27FDA Approved: CLARITHROMYCIN — Supplemental Application (Chartwell RX, LLC.)
FDA approved Chartwell RX, LLC.'s supplemental application for Clarithromycin (generic) under the ANDA process, resulting in approval of a g…
-
FDA approval · 2015-07-01FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for clarithromycin from Sandoz Inc, indicating continued/expanded approval for generic use of the dr…
-
FDA approval · 2014-09-26FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium from Teva Pharmaceuticals USA, Inc. The supplement rel…